Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Journal of Clinical Medicine|March 28, 2026
Associations of Tumor Somatic Mutations and Genetic Alterations with Survival Outcomes in Melanoma Patients Treated with IpilimumabMohammad Ali Khaksar, Islam Eljilany, Ibrahim Yassine, et al.Pharmacogenomics and Personalized Medicine|September 6, 2021
Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin ManagementIslam Eljilany, Mohamed Elarref, Nabil Shallik, et al.Current Problems in Cardiology|March 15, 2021
Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort StudyIslam Eljilany, Mohamed Elarref, Nabil Shallik, et al.International Journal of Clinical Pharmacy|June 7, 2025
Evaluating the economic impact of clinical pharmacist interventions in the women's health setting in QatarDaoud Al-Badriyeh, Shimaa Aboelbaha, Nurhan ElShafey, et al.Cancers|May 13, 2023
Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature ReviewIslam Eljilany, Arish Noor, Mahati Paravathaneni, et al.Medrxiv : the Preprint Server for Health Sciences|July 29, 2024
Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitorsXuefeng Wang, Tingyi Li, Islam Eljilany, et al.Cancers|October 28, 2023
The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint InhibitorsIslam Eljilany, Payman Ghasemi Saghand, James Chen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2025
Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-Risk MelanomaAhmad A Tarhini, Alyssa Obermayer, Sandra J Lee, et al.Journal of Oncology Research and Therapy|March 14, 2025
Differences in Co-Expression of T Cell Co-Inhibitory and Co-Stimulatory Molecules with PD-1 Across Different Human CancersAhmad A Tarhini, Dale Hedges, Aik Choon Tan, et al.Nature Communications|November 13, 2025
Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitorsXuefeng Wang, Tingyi Li, Islam Eljilany, et al.Pageof 4